Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Once fired from Anavex, ...
It’s so disappointing! George, Bas, and Xena have not been doing their job! Better try harder!
You can't file anywhere with negative trial results!
Those people never bought a share. They are pumpers for a reason.
We have a really smart CEO. He sold all @$5.11. Now the SP is $3 something and soon going to $2 something and $1 something. Will George and BASxxx apologize to the board members?
Real hope of patients with Rett may be finally coming: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2023-financial-results
There seems to be just enough to proceed to the discovery phase. The law firm will likely hire an expert in clinical trials. Then Anavex will have to disclose its SAP plans.
That's really good for you, right? Employ your dry powder and load it up when it's $1. Maybe you should take it private and hire MayoMobile as CSO.
The results are so astounding and shocking that Dr. Grimmer is given WHOLE 15 MINUTES to present. The stock will go to the Moon afterwards.
Who's better with their job? Mayo on $AVXL or Joe Springer on $SAVA?
He's a genius in extracting so much wealth from nothing in terms of trial success or investor value. Absolute genius.
You are asking too much from this board. There are only two real experts here: MayoMobile and Lane Simonian.
The $0.10 abyss.
With due respect to Dr. Jin, who said he is/was a hot commodity and in high demand? Most pharmas use external consultant (academic or private) for stats. Maybe Anavex was the only landing spot when he left......for whatever reason.
I think the estimated expenses for an AD P3 (>800 subjects) and a Rett P3 are quite conservative. My estimate would be $150 M minimum for the trials alone. The number of objects may need to be higher (the P2/3 of 500 subject did not reach statistical significance for approval). The way Missling runs the company, I put the chances of approval for 273 within 6 years for anything at zero.
As for 3-71, see you in a decade if Anavex still exists.
Well said. Phase II can be turned positive no matter what. Missling will be paid forever. There's no need for pivotal P3 studies as they will fail for AD, PD, or Rett. Why lose the cash cow for management?
Now we know that Anavex will not have anything for the next decade except paying Missling well.
Same playbook as NWBO: just withdrew guidance for the filing of its marketing application to UK regulators. The claimed DCVax submission was and is just a claim. AVXL will be no different.
I predicted that it would be in the $4s per share by the end of October. Now I am telling you that it will be in the $2s by the end of this year and it will be $3 per share at the end of 2024 after 5 to 1 reverse splitting.
Great. Please keep all your shares until $0.00. No one is buying. See the price action lately?
Delusion remains/continues even with name/handle changes. Fortunately, fewer people fall for it now.
$SAVA is going to $0. Fraud will be exposed no matter how long it takes. The other is not far behind.
End of year price prediction: $2.23.
Should have hired MayoM instead of Jin.
Great! You should prepare more dry powder. $4 is coming.
Anavex will have similar fate as $BCLI with its fuzzy math.
Inventing new endpoints is challenging and takes time. Of course, the benefits outweigh as it can turn failed trials into “successful” ones to excite the WGT cult. ODDS ratio and AUC have been taken. It will take even longer to “find” another one for the Rett trial (EXCELLENCE).
He sold 260,000 shares about a month ago for $7.98 per share. He never spent a penny of his own money to buy shares on the open market. He obtained his share either for free or pennies per share through over-bloated compensation.
Is there a lithium shortage I am not aware of? It seems that so many on this board see men in black suits chasing them.
Missling is looking smarter by the minute for selling 268,000 shares at $7.98 per. Now I am a bag holder.
We should appreciate how smart Dr. Missling is. He sold 268K shares at $7.98 end of June (or early July).
He's very good at investing as well. That's why he sold 260K shares one month ago with all the data likely on hand already.
Missling may not be good with investors or real medical science, he for sure has mastered the technique of p-hacking
strategies (https://royalsocietypublishing.org/doi/pdf/10.1098/rsos.220346).
You are asking too much! For the faithful, delusion is better than science or math.
Why not $100B. It’s all delusional anyway. Maybe 2-73 can treat delusion as well.
The more critical question is, in my opinion, what population of patients was used in the “new” analysis. The ITT was used in the initial (Dec 22) analysis, at least it was claimed.
I don’t think so: there will not be any AD P3 trial any time soon. Missling will follow the playbook of NWBO and claim success for another decade and get paid handsomely. The SP will follow as well.
0%. Guaranteed.
No one is smarter than the CEO. He sold 260K at $8 a month ago. With all the glorious results from AD and Rett……..